UP!
| 2016-06-28 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2016-03-28 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2016-03-14 | Initiated Coverage | Janney Montgomery Scott | Neutral | $8.00 |
| 2016-03-01 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2016-02-08 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2016-01-27 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2015-12-15 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2015-12-07 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2015-11-03 | Initiated Coverage | Cantor Fitzgerald | Buy | $22.00 |
| 2015-09-30 | Reiterated Rating | Guggenheim | Buy | $24.00 |
| 2015-08-07 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-08-07 | Reiterated Rating | Janney Montgomery Scott | Buy | $21.00 |
| 2015-07-02 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 |
| 2015-06-29 | Reiterated Rating | Guggenheim | Buy | $24.00 |
| 2015-06-26 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 |
| 2015-05-28 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 |
| 2015-05-11 | Initiated Coverage | Guggenheim | Buy | $24.00 |
| 2015-05-08 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 |
| 2015-04-29 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 |
| 2015-03-26 | Boost Price Target | JMP Securities | Outperform | $18.00 to $24.00 |
| 2015-03-25 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 |
| 2015-03-12 | Reiterated Rating | Canaccord Genuity | Buy | $25.00 |
| 2015-03-12 | Boost Price Target | JMP Securities | Outperform | $13.00 to $18.00 |
| 2015-02-20 | Set Price Target | Canaccord Genuity | Buy | $18.00 to $25.00 |
| 2015-01-26 | Set Price Target | Canaccord Genuity | Buy | $12.00 to $18.00 |
| 2014-09-24 | Lower Price Target | JMP Securities | Outperform | $18.00 to $13.00 |
| 2014-09-24 | Lower Price Target | Stifel Nicolaus | Buy | $20.00 to $18.00 |
| 2014-03-05 | Initiated Coverage | Canaccord Genuity | Buy | $20.00 |
| 2014-03-03 | Initiated Coverage | Janney Montgomery Scott | Buy | |
| 2014-03-03 | Initiated Coverage | Stifel Nicolaus | Buy | $20.00 |
| 2014-03-03 | Initiated Coverage | JMP Securities | Outperform | $19.00 |
| 2016-06-28 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2016-03-28 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2016-03-14 | Initiated Coverage | Janney Montgomery Scott | Neutral | $8.00 |
| 2016-03-01 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
| 2016-02-08 | Reiterated Rating | Cantor Fitzgerald | Buy | $22.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In EGLT 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| FORMELA JEAN FRANCOIS | 12.45% (2152222) | ABIO / EGLT / NTLA / |
| Atlas Venture Fund VII L P | 12.45% (2152222) | ABIO / EGLT / |
| SEGERROS ANDREAS Rutger | 10.76% (1859615) | EGLT / |
| SUNSTONE LIFE SCIENCE VENTURES FUND II K/S | 10.76% (1859615) | EGLT / |
| Index Venture Associates III Ltd | 5.83% (1007033) | EGLT / NERV / |
| Radie Robert S President and CEO | 1.94% (334900) | EGLT / TSPT / |
| Danish Biotech SPV I P/S | 1.82% (314574) | EGLT / |
| AGUIAR-LUCANDER RENEE | 1.82% (314574) | EGLT / |
| LINDHARDT KARSTEN VP, Research & Development | 0.81% (139200) | EGLT / |
| Musial Stan Chief Financial Officer | 0.71% (122407) | EGLT / |
| Shea Patrick M Chief Commercial Officer | 0.68% (117020) | EGLT / |
| Strobeck Mark Chief Business Officer | 0.53% (92080) | EGLT / |
| CARLIN BARBARA Chief Accounting Officer | 0.50% (85923) | EGLT / |
| TIMMINS MEGAN C. General Counsel | 0.47% (81500) | EGLT / |
| Melloy Deanne F. Chief Commercial Officer | 0.19% (33420) | EGLT / |
| VARKI PAUL SVP, GC & Chief Compliance Off | 0.17% (29514) | EGLT / |
| Dayno Jeffrey M. Chief Medical Officer | 0.11% (18212) | EGLT / |
UM